The abstract is read at the publisher; the summary is JClub's.
MDCK-NBL2, MDCK-I, and MDCK-II support trypsin-independent replication of multiple influenza A virus strains, with serine protease inhibition by camostat and nafamostat mesylate reducing replication.
- Why it matters: Many influenza A cell culture systems require exogenous trypsin, limiting models for studying entry and antiviral strategies that target host proteases.
- What they did: The study tested MDCK sublines for viral growth without trypsin and used dose-dependent camostat and nafamostat mesylate inhibition, then measured endogenous transmembrane serine proteases including TMPRSS2 and TMPRSS4.
- The result: TMPRSS4, but not TMPRSS2, mainly localizes to the plasma membrane and is more effective at activating various influenza viruses, enabling trypsin-free replication models and evaluation of transmembrane serine protease antivirals.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.